Tag Archives: Prof Brett Lidbury

Ross River virus immune evasion strategies & the relevance to Post-Viral Fatigue & ME onset

Posted on 04/26/2021 by wames

Ross River virus immune evasion strategies and the relevance to Post-Viral Fatigue, and Myalgic Encephalomyelitis onset, by Brett A Lidbury in Front. Med.  Vol 8, 2021 pp 298 [doi: 10.3389/fmed.2021.662513]   Article abstract: Ross River virus (RRV) is an endemic … Continue reading →

Posted in News | Tagged , , | Comments Off on Ross River virus immune evasion strategies & the relevance to Post-Viral Fatigue & ME onset

Biomedical insights that inform the diagnosis of ME/CFS

Posted on 02/24/2020 by wames

Biomedical insights that inform the diagnosis of ME/CFS, by Brett A Lidbury, & Paul R Fisher, in Diagnostics 2020, 10(2), 92; [doi.org/10.3390/diagnostics10020092] (This article belongs to the Special Issue Biomedical Insights that Inform the Diagnosis of ME/CFS)   Editorial announcing … Continue reading →

Posted in News | Tagged , , , | Comments Off on Biomedical insights that inform the diagnosis of ME/CFS

An isolated complex V inefficiency & dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients

Posted on 02/20/2020 by wames

An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients, by Daniel Missailidis, Sarah J Annesley, Claire Y Allan, Oana Sanislav, Brett A Lidbury, Donald P Lewis and Paul R Fisher in J. Mol. Sci. … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on An isolated complex V inefficiency & dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients

Towards a biomarker: Rethinking ME/CFS diagnostic reference intervals via machine learning, & the utility of activin B for defining symptom severity

Posted on 09/19/2019 by wames

Rethinking ME/CFS diagnostic reference intervals via machine learning, and the utility of activin B for defining symptom severity, by Brett A. Lidbury, Badia Kita, Alice M Richardson, Donald P Lewis, Edwina Privitera, Susan Hayward, David de Kretser and Mark Hedger … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Towards a biomarker: Rethinking ME/CFS diagnostic reference intervals via machine learning, & the utility of activin B for defining symptom severity

ME/CFS: a comprehensive review

Posted on 08/19/2019 by wames

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a comprehensive review, by Mateo Cortes Rivera, Claudio Mastronardi, Claudia T Silva-Aldana, Mauricio Arcos-Burgos and Brett A Lidbury in Diagnostics 2019, 9(3), 91; 7 August 2019[https://doi.org/10.3390/diagnostics9030091] Review abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on ME/CFS: a comprehensive review

Weighted Standing Time test as a measure of orthostatic intolerance in ME/CFS

Posted on 04/19/2018 by wames

Research abstract: Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection, by Alice M. Richardson, Don P. Lewis, Badia Kita, Helen Ludlow, Nigel P. Groome, Mark P. Hedger, David M. de Kretser, Brett A. Lidbury in Journal … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Weighted Standing Time test as a measure of orthostatic intolerance in ME/CFS

Could we finally have a definitive biomarker for ME/CFS?

Posted on 06/20/2017 by wames

ME Research UK blog post, 9 June 2017: Could we finally have a definitive biomarker for ME/CFS? It’s a recurring theme, but the diagnosis of ME/CFS is severely hampered by the lack of a test that can distinguish people with … Continue reading →

Posted in News | Tagged , , , | Comments Off on Could we finally have a definitive biomarker for ME/CFS?

Activin B – a potential biomarker for CFS/ME?

Posted on 03/21/2017 by wames

Research abstract: Background: Investigations of activin family proteins as serum biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). CFS/ME is a disease with complex, wide-ranging symptoms, featuring persistent fatigue of 6 months or longer, particularly post exertion. No definitive biomarkers are … Continue reading →

Posted in News | Tagged , , , | Comments Off on Activin B – a potential biomarker for CFS/ME?

New Australian genetic marker detection study

Posted on 11/10/2016 by wames

ME Research UK blog post, 6 November 2016: New study – Genetic marker detection Prof Brett Lidbury and colleagues at the John Curtin School of Medical Research, Australian National University in Canberra are conducting an ongoing programme, funded by charities in … Continue reading →

Posted in News | Tagged , , , , | Comments Off on New Australian genetic marker detection study